{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:18:58Z","timestamp":1794608338025,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","award":["HL19278"],"award-info":[{"award-number":["HL19278"]}],"id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","award":["UL1 TR001866"],"award-info":[{"award-number":["UL1 TR001866"]}],"id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahj.2026.107513","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:10:03Z","timestamp":1781651403000},"page":"107513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The effect of zalunfiban on high sensitivity cardiac troponin and the association with clinical outcomes in patients with STEMI"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1798","authenticated-orcid":false,"given":"James L.","family":"Januzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-1689","authenticated-orcid":false,"given":"Gerald","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-7155","authenticated-orcid":false,"given":"Barry S.","family":"Coller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sem A.O.F.","family":"Rikken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1995-6221","authenticated-orcid":false,"given":"Ashley","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurrien M. Ten","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-7564","authenticated-orcid":false,"given":"Arnoud W.J.","family":"van 't Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107513_bib0001","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.amjcard.2013.01.284","article-title":"Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention","volume":"111","author":"Boden","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107513_bib0002","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.amjcard.2010.06.050","article-title":"Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction","volume":"106","author":"Byrne","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107513_bib0003","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.amjcard.2008.11.031","article-title":"Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention","volume":"103","author":"Hassan","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107513_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001863","article-title":"Peak troponin T in STEMI: a predictor of all-cause mortality and left ventricular function","volume":"9","author":"Khullar","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.ahj.2026.107513_bib0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12872-023-03168-0","article-title":"Magnitude of troponin elevation in patients with biomarker evidence of myocardial injury: relative frequency and outcomes in a cohort study across a large healthcare system","volume":"23","author":"McIlvennan","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ahj.2026.107513_bib0006","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.amjcard.2018.05.005","article-title":"Predictive value of high-sensitivity troponin T for systolic dysfunction and infarct size (Six Months) after ST-elevation myocardial infarction","volume":"122","author":"Mohammad","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107513_bib0007","doi-asserted-by":"crossref","DOI":"10.31083\/RCM37466","article-title":"Identification and management strategies for intracoronary high thrombus burden in patients with STEMI: a practical experience and literature review","volume":"26","author":"Feng","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.ahj.2026.107513_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.646064","article-title":"Micro-CT-based quantification of extracted thrombus burden characteristics and association with angiographic outcomes in patients with ST-elevation myocardial infarction: the QUEST-STEMI study","volume":"8","author":"Karagiannidis","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ahj.2026.107513_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2025.107500","article-title":"The use of glycoprotein IIb\/IIIa inhibitors in elective PCI - a systematic review and meta-analysis of randomised trials","volume":"159","author":"Brieger","year":"2025","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.ahj.2026.107513_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092023","article-title":"Current and future roles of glycoprotein IIb-IIIa inhibitors in primary angioplasty for ST-segment elevation myocardial infarction","volume":"12","author":"De Luca","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ahj.2026.107513_bib0011","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Stenting in myocardial infarction regarding A and long-term F-u. Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107513_bib0012","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(08)61235-0","volume":"372","author":"Van't Hof","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107513_bib0013","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40292-023-00562-9","article-title":"An updated review on glycoprotein IIb\/IIIa inhibitors as antiplatelet agents: basic and clinical perspectives","volume":"30","author":"Sharifi-Rad","year":"2023","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.ahj.2026.107513_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031855","article-title":"Critical analysis of thrombocytopenia associated with glycoprotein IIb\/IIIa inhibitors and potential role of Zalunfiban, a novel small molecule glycoprotein inhibitor, in understanding the mechanism(s)","volume":"12","author":"Rikken","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107513_bib0015","article-title":"Zalunfiban: a review of current knowledge and future applications of an innovative antiplatelet agent","author":"Veasaw","year":"2024","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ahj.2026.107513_bib0016","first-page":"1","article-title":"Mass balance and metabolite profiling of (14)C-Zalunfiban in humans following single-dose subcutaneous administration","author":"MacArthur","year":"2025","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ahj.2026.107513_bib0017","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1161\/ATVBAHA.114.303724","article-title":"RUC-4: a novel alphaIIbbeta3 antagonist for prehospital therapy of myocardial infarction","volume":"34","author":"Li","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2026.107513_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ahj.2022.12.015","article-title":"investigators C. Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the CELEBRATE trial","volume":"258","author":"Rikken","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107513_bib0019","article-title":"Zalunfiban at first medical contact for ST-elevation myocardial infarction","volume":"5","author":"Van't Hof","year":"2026","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ahj.2026.107513_bib0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcmg.2017.01.008","article-title":"Myocardial infarct size by CMR in clinical cardioprotection studies: insights from randomized controlled trials","volume":"10","author":"Bulluck","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2026.107513_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311157","article-title":"Simple indices of infarct size post ST-Elevation Myocardial infarction (STEMI) provides similar risk stratification to cardiac MRI","volume":"19","author":"Sharma","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2026.107513_bib0022","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.121.054302","article-title":"Cardiac troponin thresholds and kinetics to differentiate myocardial injury and myocardial infarction","volume":"144","author":"Wereski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107513_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1637251","article-title":"The independent value and clinical significance of angio-based microvascular resistance in predicting adverse cardiovascular events in patients with acute ST-elevation myocardial infarction","volume":"12","author":"Han","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ahj.2026.107513_bib0024","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107513_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1639213","article-title":"The effect of guideline-directed medicine on patients with new-onset heart failure following acute myocardial infarction","volume":"12","author":"Lei","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ahj.2026.107513_bib0026","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0002-9149(00)01068-7","article-title":"Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes","volume":"86","author":"Januzzi","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107513_bib0027","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4244\/EIJV6I3A56","article-title":"Myocardial infarction evaluation 2 study g. Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial","volume":"6","author":"Timmer","year":"2010","journal-title":"EuroIntervention"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:24:30Z","timestamp":1787257470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S0002870326001754"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107513","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of zalunfiban on high sensitivity cardiac troponin and the association with clinical outcomes in patients with STEMI","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107513"}}